Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabrina M Ronen

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
Plos One|February 24, 2015
Metabolic reprogramming in mutant IDH1 glioma cellsJose L Izquierdo-Garcia, Pavithra Viswanath, Pia Eriksson, et al.
Molecular Cancer Therapeutics|May 30, 2006
Detection of histone deacetylase inhibition by noninvasive magnetic resonance spectroscopyMadhuri Sankaranarayanapillai, William P Tong, David S Maxwell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2022
Deuterium Metabolic Imaging Reports on TERT Expression and Early Response to Therapy in CancerGeorgios Batsios, Céline Taglang, Meryssa Tran, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 19, 2011
Detection of early response to temozolomide treatment in brain tumors using hyperpolarized 13C MR metabolic imagingIlwoo Park, Robert Bok, Tomoko Ozawa, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
Telomerase reverse transcriptase induces targetable alterations in glutathione and nucleotide biosynthesis in glioblastomasSuresh Udutha, Céline Taglang, Georgios Batsios, et al.
Neuro-Oncology Advances|November 29, 2023
Monitoring response to a clinically relevant IDH inhibitor in glioma-Hyperpolarized <sup>13</sup>C magnetic resonance spectroscopy approachesDonghyun Hong, Yaewon Kim, Chandrasekhar Mushti, et al.
Metabolites|March 6, 2021
Early Noninvasive Metabolic Biomarkers of Mutant IDH Inhibition in GliomaMarina Radoul, Donghyun Hong, Anne Marie Gillespie, et al.
Cancer Research|October 17, 2014
Changes in pyruvate metabolism detected by magnetic resonance imaging are linked to DNA damage and serve as a sensor of temozolomide response in glioblastoma cellsIlwoo Park, Joydeep Mukherjee, Motokazu Ito, et al.
Cancer & Metabolism|April 6, 2018
Mutant IDH1 gliomas downregulate phosphocholine and phosphoethanolamine synthesis in a 2-hydroxyglutarate-dependent mannerPavithra Viswanath, Marina Radoul, Jose Luis Izquierdo-Garcia, et al.
Oncotarget|May 5, 2016
Mutant IDH1 expression is associated with down-regulation of monocarboxylate transportersPavithra Viswanath, Chloe Najac, Jose L Izquierdo-Garcia, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Plos One|February 24, 2015
Metabolic reprogramming in mutant IDH1 glioma cellsJose L Izquierdo-Garcia, Pavithra Viswanath, Pia Eriksson, et al.
Molecular Cancer Therapeutics|May 30, 2006
Detection of histone deacetylase inhibition by noninvasive magnetic resonance spectroscopyMadhuri Sankaranarayanapillai, William P Tong, David S Maxwell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2022
Deuterium Metabolic Imaging Reports on TERT Expression and Early Response to Therapy in CancerGeorgios Batsios, Céline Taglang, Meryssa Tran, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 19, 2011
Detection of early response to temozolomide treatment in brain tumors using hyperpolarized 13C MR metabolic imagingIlwoo Park, Robert Bok, Tomoko Ozawa, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
Telomerase reverse transcriptase induces targetable alterations in glutathione and nucleotide biosynthesis in glioblastomasSuresh Udutha, Céline Taglang, Georgios Batsios, et al.
Neuro-Oncology Advances|November 29, 2023
Monitoring response to a clinically relevant IDH inhibitor in glioma-Hyperpolarized <sup>13</sup>C magnetic resonance spectroscopy approachesDonghyun Hong, Yaewon Kim, Chandrasekhar Mushti, et al.
Metabolites|March 6, 2021
Early Noninvasive Metabolic Biomarkers of Mutant IDH Inhibition in GliomaMarina Radoul, Donghyun Hong, Anne Marie Gillespie, et al.
Cancer Research|October 17, 2014
Changes in pyruvate metabolism detected by magnetic resonance imaging are linked to DNA damage and serve as a sensor of temozolomide response in glioblastoma cellsIlwoo Park, Joydeep Mukherjee, Motokazu Ito, et al.
Cancer & Metabolism|April 6, 2018
Mutant IDH1 gliomas downregulate phosphocholine and phosphoethanolamine synthesis in a 2-hydroxyglutarate-dependent mannerPavithra Viswanath, Marina Radoul, Jose Luis Izquierdo-Garcia, et al.
Oncotarget|May 5, 2016
Mutant IDH1 expression is associated with down-regulation of monocarboxylate transportersPavithra Viswanath, Chloe Najac, Jose L Izquierdo-Garcia, et al.
Pageof 8